STATing the importance of immune modulation by platinum chemotherapeutics

PD-1 and Its Ligands in Tolerance and Immunity

2008 • 4,838 citations

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

2007 • 2,814 citations

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

2005 • 758 citations

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

2010 • 438 citations

Cancer immunotherapy – revisited

2011 • 399 citations

Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development

2007 • 316 citations

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

2011 • 310 citations

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis

2010 • 108 citations

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients

2010 • 61 citations

STAT6 expression in glioblastoma promotes invasive growth

2011 • 41 citations